Evidence map›Paper›PMID 30759095›Full record

ArticlePloS one2019

The primate-specific peptide Y-P30 regulates morphological maturation of neocortical dendritic spines.

Janine R Neumann, Suvarna Dash-Wagh, Alexander Jack, Andrea Räk, Kay Jüngling, Mohammad I K Hamad, Hans-Christian Pape, Michael R Kreutz, Martin Puskarjov, Petra Wahle

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Pleiotrophin: Activity and mechanism.Advances in clinical chemistry · 2020
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Janine R NeumannRuhr-Universität Bochum, AG Entwicklungsneurobiologie, Fakultät für Biologie und Biotechnologie, Bochum, Germany.
Suvarna Dash-WaghRuhr-Universität Bochum, AG Entwicklungsneurobiologie, Fakultät für Biologie und Biotechnologie, Bochum, Germany.
Alexander JackRuhr-Universität Bochum, AG Entwicklungsneurobiologie, Fakultät für Biologie und Biotechnologie, Bochum, Germany.
Andrea RäkRuhr-Universität Bochum, AG Entwicklungsneurobiologie, Fakultät für Biologie und Biotechnologie, Bochum, Germany.
Kay JünglingInstitut für Physiologie I, Westfälische Wilhelms-Universität Münster, Münster, Germany.
Mohammad I K HamadRuhr-Universität Bochum, AG Entwicklungsneurobiologie, Fakultät für Biologie und Biotechnologie, Bochum, Germany.
Hans-Christian PapeInstitut für Physiologie I, Westfälische Wilhelms-Universität Münster, Münster, Germany.
Michael R KreutzNeuroplastizität, Leibniz-Institut für Neurobiologie, Madgeburg, Germany.
Martin PuskarjovMolecular and Integrative Biosciences, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland.
Petra WahleRuhr-Universität Bochum, AG Entwicklungsneurobiologie, Fakultät für Biologie und Biotechnologie, Bochum, Germany.ORCID 0000-0002-8710-0375
Ruhr University Bochum · DEUniversity of Münster · DEUniversität Hamburg · DEUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 30-amino acid peptide Y-P30 corresponds to the N-terminus of the primate-specific, sweat gland-derived dermcidin prepropeptide. Previous work has revealed that Y-P30 enhances the interaction of pleiotrophin and syndecans-2/3, and thus represents a natural ligand to study this signaling pathway. In immature neurons, Y-P30 activates the c-Src and p42/44 ERK kinase pathway, increases the amount of F-actin in axonal growth cones, and promotes neuronal survival, cell migration and axonal elongation. The action of Y-P30 on axonal growth requires syndecan-3 and heparan sulfate side chains. Whether Y-P30 has the potential to influence dendrites and dendritic protrusions has not been explored. The latter is suggested by the observations that syndecan-2 expression increases during postnatal development, that syndecan-2 becomes enriched in dendritic spines, and that overexpression of syndecan-2 in immature neurons results in a premature morphological maturation of dendritic spines. Here, analysing rat cortical pyramidal and non-pyramidal neurons in organotypic cultures, we show that Y-P30 does not alter the development of the dendritic arborization patterns. However, Y-P30 treatment decreases the density of apical, but not basal dendritic protrusions at the expense of the filopodia. Analysis of spine morphology revealed an unchanged mushroom/stubby-to-thin spine ratio and a shortening of the longest decile of dendritic protrusions. Whole-cell recordings from cortical principal neurons in dissociated cultures grown in the presence of Y-P30 demonstrated a decrease in the frequency of glutamatergic mEPSCs. Despite these differences in protrusion morphology and synaptic transmission, the latter likely attributable to presynaptic effects, calcium event rate and amplitude recorded in pyramidal neurons in organotypic cultures were not altered by Y-P30 treatment. Together, our data suggest that Y-P30 has the capacity to decelerate spinogenesis and to promote morphological, but not synaptic, maturation of dendritic protrusions.

Indexed as

AnimalsCalciumCell DifferentiationCells, CulturedDendritic SpinesNeocortexOrgan Culture TechniquesPatch-Clamp TechniquesPeptidesRatsSyndecan-2CalciumdermcidinPeptidesSdc2 protein, ratSyndecan-2

Identifiers

PMID30759095
PMCPMC6373909
OpenAlexW2914139191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.